Global ResearchRed Algae Extract Defends Against Ebola, HIV, SARS, and More
Red algae, the pigments in which are caused by compounds
known as phycoerythrin and phycocyanin, can now be known as yet another
one of Mother Nature’s answers to the latest ‘Ebola Pandemic,’ as well
as a host of other diseases ranging from HIV, Hepatitis-C, SARS, and
more. There is no need to resort to experimental nationwide Ebola vaccines as suggested by U.S. authorities and the current vaccine maker, GlaxoSmithKline.
Red algae is a key antiviral for this crazy world we are living in. Just having a healthy, strong immune system could save your life, and at least minimize your chances of getting sick where other less-propagandized sicknesses are concerned, such as the ‘flu’ or even the common cold. Compounds in red algae help to greatly promote our own natural immune systems.
When researchers were looking into more details of the Gabon Africa Ebola outbreak of 1996, they found that Ebola causes death among about 70% of those who become infected. They also note that there are many people who think that cases deemed to be Ebola are actually hemorrhagic fevers, like Dengue, because they present the very same symptoms.
In any case, this 70% statistic led researchers from Gabon’s Franceville International Center of Medical Research to investigate more fully. How did 30% of the people exposed to Ebola live, even when they were in close contact with Ebola victims?
(Currently, there is controversy as to how Ebola is transmitted. Some say it can be airborne, which could mean it isn’t Ebola, and others say it must be contracted only through direct mucosal or blood such as a transfer of saliva, urine, semen or blood from one person to another.)
These researchers found that nearly half of those who were asymptomatic and seemingly immune developed antibodies (IgM and IgG) to the Ebola virus. Antibodies are protective proteins that guard against disease in the body, and they normally occur naturally in a healthy person.
They also noted that the asymptomatic group exhibited fewer inflammatory responses in general. Not to be too graphic, but Ebola is said to ‘liquefy’ the insides, which is a bit of an exaggeration It does cause extreme inflammation, though, which can eventually lead to heavy bleeding and death.
The asymptomatic group was also found to have higher levels of circulating cytokines and chemokines – which speed up the body’s ability to break down viral cells and stop them from causing people to be sick.
This happens in many diseases, not just Ebola. Mannose-binding lectins attack the Ebola virus but also other lethal infections like HIV, HCV and SARS.
Mannose-binding lectins are produced in the human body via a DNA sequence, called the MBL2. When our genes are working properly, these lectins flood the bloodstream and scourge disease – including unwanted fungi, bacteria, and even parasites, which utilize glycoprotein shells to protect themselves. They also inhibit virus growth.
They do this by breaking apart the surface of the unwanted microbe and breaking them down, allowing the body’s additional immune cells to kill off the virus or toxin and prevent it from replicating.
Research over the past five years has found that low levels of mannose-binding lectins increases the risk of respiratory infections, including syncytial virus infections, pneumonia and others.
Ebola, as many other viruses do, comes with a glycoprotein shell that must be broken down in order for someone who is in contact with it to remain healthy.
Where Red Algae Comes into Play
Furthermore, the glycoprotein shell of the Ebola virus produces glycoproteins that damage cells, allowing the virus to penetrate and replicate within the cell – but red algae has been shown to keep this from happening.
The reason for this mutation/switch-off has yet to be fully understood.
Red algae produces mannose-binding lectins plentifully, which allow the plants to protect themselves from invasion by viruses.
The most promising form of mannose-binding lectins is a component of the Scytonema varium red algae called Scytovirin. The protein extract was isolated by researchers from the National Cancer Institute at Frederick, Maryland in 2003. It contains 95 amino acids, and was found to bind to HIV-1 viral shells.
Another antiviral protein in red algea broke down the glycoprotein shells of HIV and HCV.
And yet another anti-viral extract found in a New Zealand red algae species, Griffithsia sp.. The anti-vrial, Griffithsin, was beneficial in treating mice with epidemic-potentiated SARS and also HIV-1. It stopped the viruses from replicating.
Here’s the Real Proof
In 2010, Harvard researchers tested a recombinant version of Griffithsin – called rhMBL – against Ebola, and found that it broke down those pesky viral shells while giving mice complete immunity to the virus. Other animals have since been tested with similar results.
So, even if you aren’t certain red algae will keep you from contracting Ebola, you can boost your immune system and protect against a number of diseases, from Ebola to SARS, simply by taking a red seaweed supplement.
No fear here.
Additional Sources:
Nat Med. 1999 Apr;5(4):423-6.
Lancet. 2000 Jun 24;355(9222):2210-5.
Int J Chron Obstruct Pulmon Dis. 2012;7:767-77. doi: 10.2147/COPD.S33714.
J Clin Immunol. 2008 Mar;28(2):166-73.
Antimicrob Agents Chemother. 2014;58(1):120-7. doi: 10.1128/AAC.01407-13.
PLoS One. 2013 May 21;8(5):e64449. doi: 10.1371/journal.pone.0064449.
J Biol Chem. 2005 Mar 11;280(10):9345-53.
Biochemistry. 2003 Mar 11;42(9):2578-84.
J Infect Dis. 2011 Jan 15;203(2):175-9. doi: 10.1093/infdis/jiq025.
Int Immunopharmacol. 2001 Apr;1(4):677-87.
Crit Rev Microbiol. 2013 Jul 16.
Red algae is a key antiviral for this crazy world we are living in. Just having a healthy, strong immune system could save your life, and at least minimize your chances of getting sick where other less-propagandized sicknesses are concerned, such as the ‘flu’ or even the common cold. Compounds in red algae help to greatly promote our own natural immune systems.
When researchers were looking into more details of the Gabon Africa Ebola outbreak of 1996, they found that Ebola causes death among about 70% of those who become infected. They also note that there are many people who think that cases deemed to be Ebola are actually hemorrhagic fevers, like Dengue, because they present the very same symptoms.
In any case, this 70% statistic led researchers from Gabon’s Franceville International Center of Medical Research to investigate more fully. How did 30% of the people exposed to Ebola live, even when they were in close contact with Ebola victims?
(Currently, there is controversy as to how Ebola is transmitted. Some say it can be airborne, which could mean it isn’t Ebola, and others say it must be contracted only through direct mucosal or blood such as a transfer of saliva, urine, semen or blood from one person to another.)
These researchers found that nearly half of those who were asymptomatic and seemingly immune developed antibodies (IgM and IgG) to the Ebola virus. Antibodies are protective proteins that guard against disease in the body, and they normally occur naturally in a healthy person.
They also noted that the asymptomatic group exhibited fewer inflammatory responses in general. Not to be too graphic, but Ebola is said to ‘liquefy’ the insides, which is a bit of an exaggeration It does cause extreme inflammation, though, which can eventually lead to heavy bleeding and death.
The asymptomatic group was also found to have higher levels of circulating cytokines and chemokines – which speed up the body’s ability to break down viral cells and stop them from causing people to be sick.
This happens in many diseases, not just Ebola. Mannose-binding lectins attack the Ebola virus but also other lethal infections like HIV, HCV and SARS.
Mannose-binding lectins are produced in the human body via a DNA sequence, called the MBL2. When our genes are working properly, these lectins flood the bloodstream and scourge disease – including unwanted fungi, bacteria, and even parasites, which utilize glycoprotein shells to protect themselves. They also inhibit virus growth.
They do this by breaking apart the surface of the unwanted microbe and breaking them down, allowing the body’s additional immune cells to kill off the virus or toxin and prevent it from replicating.
Research over the past five years has found that low levels of mannose-binding lectins increases the risk of respiratory infections, including syncytial virus infections, pneumonia and others.
Ebola, as many other viruses do, comes with a glycoprotein shell that must be broken down in order for someone who is in contact with it to remain healthy.
Where Red Algae Comes into Play
Furthermore, the glycoprotein shell of the Ebola virus produces glycoproteins that damage cells, allowing the virus to penetrate and replicate within the cell – but red algae has been shown to keep this from happening.
The reason for this mutation/switch-off has yet to be fully understood.
Red algae produces mannose-binding lectins plentifully, which allow the plants to protect themselves from invasion by viruses.
The most promising form of mannose-binding lectins is a component of the Scytonema varium red algae called Scytovirin. The protein extract was isolated by researchers from the National Cancer Institute at Frederick, Maryland in 2003. It contains 95 amino acids, and was found to bind to HIV-1 viral shells.
Another antiviral protein in red algea broke down the glycoprotein shells of HIV and HCV.
And yet another anti-viral extract found in a New Zealand red algae species, Griffithsia sp.. The anti-vrial, Griffithsin, was beneficial in treating mice with epidemic-potentiated SARS and also HIV-1. It stopped the viruses from replicating.
Here’s the Real Proof
In 2010, Harvard researchers tested a recombinant version of Griffithsin – called rhMBL – against Ebola, and found that it broke down those pesky viral shells while giving mice complete immunity to the virus. Other animals have since been tested with similar results.
So, even if you aren’t certain red algae will keep you from contracting Ebola, you can boost your immune system and protect against a number of diseases, from Ebola to SARS, simply by taking a red seaweed supplement.
No fear here.
Additional Sources:
Nat Med. 1999 Apr;5(4):423-6.
Lancet. 2000 Jun 24;355(9222):2210-5.
Int J Chron Obstruct Pulmon Dis. 2012;7:767-77. doi: 10.2147/COPD.S33714.
J Clin Immunol. 2008 Mar;28(2):166-73.
Antimicrob Agents Chemother. 2014;58(1):120-7. doi: 10.1128/AAC.01407-13.
PLoS One. 2013 May 21;8(5):e64449. doi: 10.1371/journal.pone.0064449.
J Biol Chem. 2005 Mar 11;280(10):9345-53.
Biochemistry. 2003 Mar 11;42(9):2578-84.
J Infect Dis. 2011 Jan 15;203(2):175-9. doi: 10.1093/infdis/jiq025.
Int Immunopharmacol. 2001 Apr;1(4):677-87.
Crit Rev Microbiol. 2013 Jul 16.
Disclaimer: The contents of this article are of sole
responsibility of the author(s). The Centre for Research on
Globalization will not be responsible for any inaccurate or incorrect
statement in this article. The Center of Research on Globalization
grants permission to cross-post original Global Research articles on
community internet sites as long as the text & title are not
modified. The source and the author's copyright must be displayed. For
publication of Global Research articles in print or other forms
including commercial internet sites, contact: publications@globalresearch.ca
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.
For media inquiries: publications@globalresearch.ca
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.
For media inquiries: publications@globalresearch.ca
Copyright © Christina Sarich, Natural Society, 2014
No comments:
Post a Comment